GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma

Abstract

These results suggest that GOLPH3 expression is likely to have important roles in RCC development and progression, and that GOLPH3 is a prognostic biomarker and a promising therapeutic target for RCC.